Managing Olanzapine Toxicity: A Comprehensive Review of Adverse Effects and Treatment Strategies

Olanzapine, a second-generation antipsychotic medication, has become a cornerstone in the treatment of schizophrenia and bipolar disorder since its introduction in 1996. While highly effective for managing psychotic symptoms and mood stabilization, olanzapine is associated with a distinctive adverse effect profile that requires careful clinical management. This comprehensive review examines the pharmacological mechanisms underlying olanzapine toxicity, systematically categorizes its adverse effects, and provides evidence-based treatment strategies for clinicians. The review encompasses metabolic disturbances, cardiovascular complications, neurological effects, and acute overdose management. Particular attention is given to the dose-dependent nature of adverse effects and the importance of personalized monitoring protocols. Understanding the complex interplay between olanzapine's therapeutic benefits and potential toxicities is essential for optimizing patient outcomes while minimizing iatrogenic harm. This article synthesizes current evidence to provide practical guidance for healthcare professionals managing patients receiving olanzapine therapy.